Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

System strengthening to support value-based care and healthy ageing for people with chronic pain.

Briggs AM, Slater H, Hsieh E, Kopansky-Giles D, Åkesson KE, Dreinhöfer KE, March LM, Woolf AD.

Pain. 2019 Jun;160(6):1240-1244. doi: 10.1097/j.pain.0000000000001526. No abstract available.

PMID:
30908354
2.

Uptake of the OMERACT-OARSI Hip and Knee Osteoarthritis Core Outcome Set: Review of Randomized Controlled Trials from 1997 to 2017.

Smith TO, Mansfield M, Hawker GA, Hunter DJ, March LM, Boers M, Shea BJ, Christensen R, Guillemin F, Terwee CB, Williamson PR, Roos EM, Loeser RF, Schnitzer TJ, Kloppenburg M, Neogi T, Ladel CH, Kalsi G, Kaiser U, Buttel TW, Ashford AE, Mobasheri A, Arden NK, Tennant A, Hochberg MC, de Wit M, Tugwell P, Conaghan PG.

J Rheumatol. 2019 Aug;46(8):976-980. doi: 10.3899/jrheum.181066. Epub 2019 Mar 1.

PMID:
30824657
3.

Instrument Selection Using the OMERACT Filter 2.1: The OMERACT Methodology.

Beaton DE, Maxwell LJ, Shea BJ, Wells GA, Boers M, Grosskleg S, Bingham CO 3rd, Conaghan PG, D'Agostino MA, de Wit MP, Gossec L, March LM, Simon LS, Singh JA, Strand V, Tugwell P.

J Rheumatol. 2019 Aug;46(8):1028-1035. doi: 10.3899/jrheum.181218. Epub 2019 Feb 1.

PMID:
30709952
4.

The OMERACT-OARSI Core Domain Set for Measurement in Clinical Trials of Hip and/or Knee Osteoarthritis.

Smith TO, Hawker GA, Hunter DJ, March LM, Boers M, Shea BJ, Christensen R, Guillemin F, Terwee CB, Williamson PR, Dodd S, Roos EM, Loeser RF, Schnitzer TJ, Kloppenburg M, Neogi T, Ladel CH, Kalsi G, Kaiser U, Buttel TW, Ashford AE, Mobasheri A, Arden NK, Tennant A, Hochberg MC, de Wit M, Tugwell P, Conaghan PG.

J Rheumatol. 2019 Aug;46(8):981-989. doi: 10.3899/jrheum.181194. Epub 2019 Jan 15.

PMID:
30647185
5.

The Global Burden of Musculoskeletal Pain-Where to From Here?

Blyth FM, Briggs AM, Schneider CH, Hoy DG, March LM.

Am J Public Health. 2019 Jan;109(1):35-40. doi: 10.2105/AJPH.2018.304747. Epub 2018 Nov 29.

6.

Comorbidities Only Account for a Small Proportion of Excess Mortality After Fracture: A Record Linkage Study of Individual Fracture Types.

Chen W, Simpson JM, March LM, Blyth FM, Bliuc D, Tran T, Nguyen TV, Eisman JA, Center JR.

J Bone Miner Res. 2018 May;33(5):795-802. doi: 10.1002/jbmr.3374. Epub 2018 Mar 23.

7.

Importance of musculoskeletal health and functional capacity through the life course.

Woolf AD, Crotty M, March LM.

Best Pract Res Clin Rheumatol. 2017 Apr;31(2):113-114. doi: 10.1016/j.berh.2017.11.005. Epub 2017 Nov 15. No abstract available.

PMID:
29224690
8.

Engaging Stakeholders and Promoting Uptake of OMERACT Core Outcome Instrument Sets.

Tunis SR, Maxwell LJ, Graham ID, Shea BJ, Beaton DE, Bingham CO 3rd, Brooks P, Conaghan PG, D'Agostino MA, de Wit MP, Gossec L, March LM, Simon LS, Singh JA, Strand V, Wells GA, Tugwell P.

J Rheumatol. 2017 Oct;44(10):1551-1559. doi: 10.3899/jrheum.161273. Epub 2017 Aug 1.

9.

An OMERACT Initiative Toward Consensus to Identify and Characterize Candidate Contextual Factors: Report from the Contextual Factors Working Group.

Finger ME, Boonen A, Woodworth TG, Escorpizo R, Christensen R, Nielsen SM, Leong AL, Scholte Voshaar M, Flurey CA, Milman N, Verstappen SM, Alten R, Guillemin F, Kloppenburg M, Beaton DE, Tugwell PS, March LM, Furst DE, Pohl C.

J Rheumatol. 2017 Nov;44(11):1734-1739. doi: 10.3899/jrheum.161200. Epub 2017 May 1.

PMID:
28461648
10.

Using aggregated general practice data to evaluate primary care interventions.

Staff M, Roberts C, March LM.

Med J Aust. 2017 Apr 3;206(6):242-243. No abstract available.

PMID:
28359001
11.

Aberrant levels of natural IgM antibodies in osteoarthritis and rheumatoid arthritis patients in comparison to healthy controls.

Nguyen TG, McKelvey KJ, March LM, Hunter DJ, Xue M, Jackson CJ, Morris JM.

Immunol Lett. 2016 Feb;170:27-36. doi: 10.1016/j.imlet.2015.12.009. Epub 2015 Dec 29.

PMID:
26744098
12.

Supplementation with omega-3 fish oil has no effect on bone mineral density in adults with knee osteoarthritis: a 2-year randomized controlled trial.

Chen JS, Hill CL, Lester S, Ruediger CD, Battersby R, Jones G, Cleland LG, March LM.

Osteoporos Int. 2016 May;27(5):1897-905. doi: 10.1007/s00198-015-3438-x. Epub 2015 Dec 22.

PMID:
26694596
13.

Pregnancy Outcomes in Women With Rare Autoimmune Diseases.

Chen JS, Roberts CL, Simpson JM, March LM.

Arthritis Rheumatol. 2015 Dec;67(12):3314-23. doi: 10.1002/art.39311.

14.

Fish oil in knee osteoarthritis: a randomised clinical trial of low dose versus high dose.

Hill CL, March LM, Aitken D, Lester SE, Battersby R, Hynes K, Fedorova T, Proudman SM, James M, Cleland LG, Jones G.

Ann Rheum Dis. 2016 Jan;75(1):23-9. doi: 10.1136/annrheumdis-2014-207169. Epub 2015 Sep 9.

PMID:
26353789
15.

The Impact of Fracture Incidence on Health Related Quality of Life among Community-Based Postmenopausal Women.

Barcenilla-Wong AL, Chen JS, Cross MJ, March LM.

J Osteoporos. 2015;2015:717914. doi: 10.1155/2015/717914. Epub 2015 Jul 30.

16.

Recommendations for the Involvement of Patient Research Partners (PRP) in OMERACT Working Groups. A Report from the OMERACT 2014 Working Group on PRP.

Cheung PP, de Wit M, Bingham CO 3rd, Kirwan JR, Leong A, March LM, Montie P, Scholte-Voshaar M, Gossec L.

J Rheumatol. 2016 Jan;43(1):187-93. doi: 10.3899/jrheum.141011. Epub 2015 Apr 15. Review.

PMID:
25877496
17.

Preventing musculoskeletal disability. Preface.

Woolf AD, March LM.

Best Pract Res Clin Rheumatol. 2014 Jun;28(3):351. doi: 10.1016/j.berh.2014.10.020. Epub 2014 Nov 15. No abstract available.

PMID:
25481419
18.

Patient outcomes using Wii-enhanced rehabilitation after total knee replacement - the TKR-POWER study.

Negus JJ, Cawthorne DP, Chen JS, Scholes CJ, Parker DA, March LM.

Contemp Clin Trials. 2015 Jan;40:47-53. doi: 10.1016/j.cct.2014.11.007. Epub 2014 Nov 12.

PMID:
25460343
19.

Vitamin D response of older people in residential aged care to sunlight-derived ultraviolet radiation.

Durvasula S, Gies P, Mason RS, Chen JS, Henderson S, Seibel MJ, Sambrook PN, March LM, Lord SR, Kok C, Macara M, Parmenter TR, Cameron ID.

Arch Osteoporos. 2014;9:197. doi: 10.1007/s11657-014-0197-9. Epub 2014 Oct 14.

PMID:
25311734
20.

Concern and risk perception: effects on osteoprotective behaviour.

Barcenilla-Wong AL, Chen JS, March LM.

J Osteoporos. 2014;2014:142546. doi: 10.1155/2014/142546. Epub 2014 Sep 8.

21.

Managing osteoporosis with FRAX® in Australia: proposed new treatment thresholds from the 45&Up Study cohort.

Chen JS, Simpson JM, Blyth FM, March LM.

Bone. 2014 Dec;69:148-53. doi: 10.1016/j.bone.2014.09.015. Epub 2014 Sep 28.

PMID:
25263521
22.

Smoking did not modify the effects of anti-TNF treatment on health-related quality of life among Australian ankylosing spondylitis patients.

Kydd AS, Chen JS, Makovey J, Chand V, Henderson L, Buchbinder R, Lassere M, March LM.

Rheumatology (Oxford). 2015 Feb;54(2):310-7. doi: 10.1093/rheumatology/keu314. Epub 2014 Aug 29.

PMID:
25173348
23.

Models of care for musculoskeletal health in Australia: now more than ever to drive evidence into health policy and practice.

Briggs AM, Towler SC, Speerin R, March LM.

Aust Health Rev. 2014 Sep;38(4):401-5. doi: 10.1071/AH14032.

PMID:
25086678
24.

Reflecting on the global burden of musculoskeletal conditions: lessons learnt from the global burden of disease 2010 study and the next steps forward.

Hoy DG, Smith E, Cross M, Sanchez-Riera L, Blyth FM, Buchbinder R, Woolf AD, Driscoll T, Brooks P, March LM.

Ann Rheum Dis. 2015 Jan;74(1):4-7. doi: 10.1136/annrheumdis-2014-205393. Epub 2014 Jun 9. Review.

PMID:
24914071
25.

The global burden of musculoskeletal conditions for 2010: an overview of methods.

Hoy DG, Smith E, Cross M, Sanchez-Riera L, Buchbinder R, Blyth FM, Brooks P, Woolf AD, Osborne RH, Fransen M, Driscoll T, Vos T, Blore JD, Murray C, Johns N, Naghavi M, Carnahan E, March LM.

Ann Rheum Dis. 2014 Jun;73(6):982-9. doi: 10.1136/annrheumdis-2013-204344. Epub 2014 Feb 18.

PMID:
24550172
26.

Placing the global burden of low back pain in context.

Buchbinder R, Blyth FM, March LM, Brooks P, Woolf AD, Hoy DG.

Best Pract Res Clin Rheumatol. 2013 Oct;27(5):575-89. doi: 10.1016/j.berh.2013.10.007. Epub 2013 Oct 12. Review.

PMID:
24315140
27.

Concern and risk perception of osteoporosis and fracture among post-menopausal Australian women: results from the Global Longitudinal Study of Osteoporosis in Women (GLOW) cohort.

Barcenilla-Wong AL, Chen JS, March LM.

Arch Osteoporos. 2013;8:155. doi: 10.1007/s11657-013-0155-y. Epub 2013 Oct 9.

PMID:
24105339
28.

Comparative effectiveness of anti-tumor necrosis factor drugs on health-related quality of life among patients with inflammatory arthritis.

Chen JS, Makovey J, Lassere M, Buchbinder R, March LM.

Arthritis Care Res (Hoboken). 2014 Mar;66(3):464-72. doi: 10.1002/acr.22151.

29.

A nested case-control analysis of self-reported physical functioning after total knee replacement surgery in the 45 and Up Study Cohort.

Rogers KD, Blyth FM, March LM, Jorm L.

BMJ Open. 2013 Jul 8;3(7). pii: e002291. doi: 10.1136/bmjopen-2012-002291. Print 2013.

30.

Pregnancy outcomes in women with juvenile idiopathic arthritis: a population-based study.

Chen JS, Ford JB, Roberts CL, Simpson JM, March LM.

Rheumatology (Oxford). 2013 Jun;52(6):1119-25. doi: 10.1093/rheumatology/kes428. Epub 2013 Feb 4.

PMID:
23382363
31.

Musculoskeletal pain on the global stage: what next?

Blyth FM, Hoy DG, March LM.

Transl Behav Med. 2012 Mar;2(1):117-9. doi: 10.1007/s13142-011-0091-6.

32.

Associations between drug burden index and mortality in older people in residential aged care facilities.

Wilson NM, Hilmer SN, March LM, Chen JS, Gnjidic D, Mason RS, Cameron ID, Sambrook PN.

Drugs Aging. 2012 Feb 1;29(2):157-65. doi: 10.2165/11598570-000000000-00000.

PMID:
22276959
33.

OARSI/OMERACT initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis. An OMERACT 10 Special Interest Group.

Gossec L, Paternotte S, Bingham CO 3rd, Clegg DO, Coste P, Conaghan PG, Davis AM, Giacovelli G, Gunther KP, Hawker G, Hochberg MC, Jordan JM, Katz JN, Kloppenburg M, Lanzarotti A, Lim K, Lohmander LS, Mahomed NN, Maillefert JF, Manno RL, March LM, Mazzuca SA, Pavelka K, Punzi L, Roos EM, Rovati LC, Shi H, Singh JA, Suarez-Almazor ME, Tajana-Messi E, Dougados M; OARSI-OMERACT Task Force Total Articular Replacement as Outcome Measure in OA.

J Rheumatol. 2011 Aug;38(8):1765-9. doi: 10.3899/jrheum.110403.

34.

Epidemiology of gout: an update.

Smith EU, Díaz-Torné C, Perez-Ruiz F, March LM.

Best Pract Res Clin Rheumatol. 2010 Dec;24(6):811-27. doi: 10.1016/j.berh.2010.10.004. Review.

PMID:
21665128
35.

Carpal tunnel syndrome and its relationship to occupation: a meta-analysis.

Barcenilla A, March LM, Chen JS, Sambrook PN.

Rheumatology (Oxford). 2012 Feb;51(2):250-61. doi: 10.1093/rheumatology/ker108. Epub 2011 May 17.

PMID:
21586523
36.

Associations between drug burden index and falls in older people in residential aged care.

Wilson NM, Hilmer SN, March LM, Cameron ID, Lord SR, Seibel MJ, Mason RS, Chen JS, Cumming RG, Sambrook PN.

J Am Geriatr Soc. 2011 May;59(5):875-80. doi: 10.1111/j.1532-5415.2011.03386.x. Epub 2011 May 3.

PMID:
21539525
37.

Does increased sunlight exposure work as a strategy to improve vitamin D status in the elderly: a cluster randomised controlled trial.

Sambrook PN, Cameron ID, Chen JS, Cumming RG, Durvasula S, Herrmann M, Kok C, Lord SR, Macara M, March LM, Mason RS, Seibel MJ, Wilson N, Simpson JM.

Osteoporos Int. 2012 Feb;23(2):615-24. doi: 10.1007/s00198-011-1590-5. Epub 2011 Mar 3.

PMID:
21369788
38.

Contribution of a common variant in the promoter of the 1-α-hydroxylase gene (CYP27B1) to fracture risk in the elderly.

Clifton-Bligh RJ, Nguyen TV, Au A, Bullock M, Cameron I, Cumming R, Chen JS, March LM, Seibel MJ, Sambrook PN.

Calcif Tissue Int. 2011 Feb;88(2):109-16. doi: 10.1007/s00223-010-9434-4. Epub 2010 Nov 25.

39.

Oral bisphosphonates are associated with reduced mortality in frail older people: a prospective five-year study.

Sambrook PN, Cameron ID, Chen JS, March LM, Simpson JM, Cumming RG, Seibel MJ.

Osteoporos Int. 2011 Sep;22(9):2551-6. doi: 10.1007/s00198-010-1444-6. Epub 2010 Oct 20.

PMID:
20959963
40.

Medication safety in residential aged-care facilities: a perspective.

Wilson NM, March LM, Sambrook PN, Hilmer SN.

Ther Adv Drug Saf. 2010 Oct;1(1):11-20. doi: 10.1177/2042098610381418. Review.

41.

Low-trauma fractures indicate increased risk of hip fracture in frail older people.

Chen JS, Cameron ID, Simpson JM, Seibel MJ, March LM, Cumming RG, Lord SR, Sambrook PN.

J Bone Miner Res. 2011 Feb;26(2):428-33. doi: 10.1002/jbmr.216.

42.

Impact of adverse news media on prescriptions for osteoporosis: effect on fractures and mortality.

Sambrook PN, Chen JS, Simpson JM, March LM.

Med J Aust. 2010 Aug 2;193(3):154-6.

PMID:
20678043
43.

Associations between drug burden index and physical function in older people in residential aged care facilities.

Wilson NM, Hilmer SN, March LM, Cameron ID, Lord SR, Seibel MJ, Sambrook PN.

Age Ageing. 2010 Jul;39(4):503-7. doi: 10.1093/ageing/afq053. Epub 2010 May 25. No abstract available.

PMID:
20501606
44.

Sunlight and health: attitudes of older people living in intermediate care facilities in southern Australia.

Durvasula S, Kok C, Sambrook PN, Cumming RG, Lord SR, March LM, Mason RS, Seibel MJ, Simpson JM, Cameron ID.

Arch Gerontol Geriatr. 2010 Nov-Dec;51(3):e94-9. doi: 10.1016/j.archger.2010.01.008. Epub 2010 Feb 11.

PMID:
20153063
45.

Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus.

O'Neill SG, Giles I, Lambrianides A, Manson J, D'Cruz D, Schrieber L, March LM, Latchman DS, Isenberg DA, Rahman A.

Arthritis Rheum. 2010 Mar;62(3):845-54. doi: 10.1002/art.27286.

46.

Differences and similarities between ankylosing spondylitis and rheumatoid arthritis: epidemiology.

Cross MJ, Smith EU, Zochling J, March LM.

Clin Exp Rheumatol. 2009 Jul-Aug;27(4 Suppl 55):S36-42.

PMID:
19822044
47.

Evidence-based guidelines for the management of hip fractures in older persons: an update.

Mak JC, Cameron ID, March LM; National Health and Medical Research Council.

Med J Aust. 2010 Jan 4;192(1):37-41. Review.

PMID:
20047547
48.

A selection strategy was developed for fracture reduction programs in frail older people.

Chen JS, Sambrook PN, Simpson JM, March LM, Cumming RG, Seibel MJ, Lord SR, Cameron ID.

J Clin Epidemiol. 2010 Jun;63(6):679-85. doi: 10.1016/j.jclinepi.2009.08.018.

PMID:
19926449
49.

Hip fracture causes excess mortality owing to cardiovascular and infectious disease in institutionalized older people: a prospective 5-year study.

Cameron ID, Chen JS, March LM, Simpson JM, Cumming RG, Seibel MJ, Sambrook PN.

J Bone Miner Res. 2010 Apr;25(4):866-72. doi: 10.1359/jbmr.091029.

50.

Should response rules be used to decide continued subsidy of very expensive drugs? A checklist for decision makers.

Bell KJ, Irwig L, March LM, Hayen A, Macaskill P, Craig JC.

Pharmacoepidemiol Drug Saf. 2010 Jan;19(1):99-105. doi: 10.1002/pds.1868.

PMID:
19802829

Supplemental Content

Loading ...
Support Center